Tempest Therapeutics, Inc. Income Taxes Receivable, Current
Tempest Therapeutics, Inc. (TPST) had Income Taxes Receivable, Current of $300.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Notes › Receivables › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2021-05-13
- 2021-03-31: Income Taxes Receivable, Current $300.00K.
- 2020-12-31: Income Taxes Receivable, Current $314.00K.
- 2020-09-30: Income Taxes Receivable, Current $244.00K.
- 2020-06-30: Income Taxes Receivable, Current $210.00K.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2021-03-31 | $300.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $314.00K 10-Q · filed 2021-05-13 |
| 2020-09-30 | $244.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $210.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.54M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.28M 10-K · filed 2021-03-29 |
| 2019-09-30 | $1.31M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $2.12M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $1.53M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.33M 10-K · filed 2020-03-11 |
| 2017-12-31 | $1.03M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |